Hims & Hers Health CTO Elshenawy Mohamed sold 7,954 shares at $28.39 each, with the transaction dated September 15, 2026. For investors, the disclosed sale represented about 4.1% of Mohamed’s prior shareholding, while his reported ownership after the transaction stood at 185,556 shares.
Key Highlights
- Elshenawy Mohamed sold 7,954 Hims & Hers Health shares at $28.39 per share on September 15, 2026.
- The transaction carried SEC transaction code S.
- Mohamed’s reported ownership after the transaction was 185,556 shares.
Elshenawy Mohamed sold 7,954 Hims & Hers Health (NYSE: HIMS) shares at $28.39 per share.
September 15 Sale at $28.39 Per Share
The sale was dated September 15, 2026, and carried transaction code S. The stated $28.39 figure represents the price for each share sold.
Post-Transaction Ownership and Stated Holding Measure
Mohamed owned 185,556 shares after the transaction. The sale represented about 4.1% of his prior shares holding, according to the disclosed calculation. Transaction code S denotes an open-market or private sale.
FAQs
Q: How many Hims & Hers Health shares did Elshenawy Mohamed sell?
A: Elshenawy Mohamed sold 7,954 Hims & Hers Health shares. The transaction price was $28.39 per share, and the sale was dated September 15, 2026.
Q: How many Hims & Hers Health shares did Mohamed own after the sale?
A: Elshenawy Mohamed’s reported post-transaction ownership was 185,556 Hims & Hers Health shares. The holding followed the disclosed sale of 7,954 shares.
Q: What percentage of Mohamed’s prior holding did the Hims & Hers Health sale represent?
A: The transaction represented about 4.1% of Elshenawy Mohamed’s prior shares holding. The percentage refers to the position before the sale, not his reported ownership afterward.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.